Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients-Reference-Cited by-同舟云学术

Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients

Published:2013-07-10 Issue:6 Volume:49 Page:574-580
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Kamalaporn Harutai¹,Leung Kitty²,Nagel Mark³,Kittanakom Saranya⁴,Calvieri Battista⁵,Reithmeier Reinhart A.F.⁴,Coates Allan L.⁶

Affiliation:

1. Division of Pulmonology, Department of Pediatrics; Ramathibodi Hospital, Mahidol University; Bangkok Thailand

2. Physiology and Experimental Medicine; Research Institute, The Hospital for Sick Children; Toronto Ontario Canada

3. Trudell Medical International; London Ontario Canada

4. Department of Biochemistry; University of Toronto; Toronto Canada

5. Faculty of Medicine, Microscopy Imaging Laboratory; University of Toronto; Toronto Ontario Canada

6. Physiology and Experimental Medicine; The Hospital for Sick Children-Research Institute, University of Toronto; Toronto Ontario Canada

Funder

none reported

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ppul.22856/fullpdf

Reference31 articles.

1. Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial;Schwartz;Blood,1999

2. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis;Allen;J Antimicrob Chemother,1994

3. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model;Olson;Antimicrob Agents Chemother,2006

4. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis;Gavalda;Antimicrob Agents Chemother,2005

5. Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats;Ruijgrok;J Antimicrob Chemother,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2024-08-01

2. Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): Results of an open‐label randomized controlled trial;Mycoses;2023-04-24

3. Preclinical Studies of the Nebulized Delivery of Liposomal Amphotericin B;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2022-12-01

4. Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement;Journal of Fungi;2022-02-21

5. Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses;Current Pharmaceutical Design;2021-04